Table 5. Effect of complement receptor blocking on the presentation of major histocompatibility complex class II molecules and the expression of co-stimulatory molecules on monocytes infected with the dengue virus.

Co-expression	No blocking	Blocking with anti-CD35	Blocking with anti-CD11b
	% monocytes infected	% monocytes infected	% monocytes infected
CR1 (CD35)+CD86+, median (range)	3.2 (1.9–6.2)	2.0 (1.3–3.5)	6.3 (2.8–7.6)
CR3 (CD11b)+CD86+, median (range)	19.6 (11.4–43.0)	26.8 (18.6–59.3)	23.6 (14.4–44.3)
CR4 (CD11c)+CD86+, median (range)	13.2 (10.8–30.0)	13.4 (9.8–34.6)	13.9 (12.6–23.0)
CD59+HLA-DR+, median (range)	85.7 (67.2–93.2)	89.2 (63.9–97.3)	89.9 (66.7–95.0)
CD59+CD40+, median (range)	5.0 (4.2–17.0)	5.3 (1.4–8.9)	4.4 (3.4–9.1)